Dutch cultured meat company Meatable has raised an additional US$35 million via an investment round led by Agronomics, bringing the company’s total funding to $95 million.
Dutch impact fund Invest-NL came on board its newest investor, with existing investors BlueYard, Bridford, MilkyWay, DSM Venturing, and Taavet Hinrikus expressing renewed support for the company.
The funding will be used to scale the company’s manufacturing process and accelerate the launch of its cultivated meat products, particularly its cultivated pork.
To create cultivated pork, the company takes a cell sample from an animal without harming it and replicates a natural growth process of cells using patented opti-ox technology combined with pluripotent stem cells.
The combined technology allows the company to produce “real muscle and fat cells” in eight days.
Krijin de Nood, co-founder and CEO of Meatable, said the continued investments are a huge sign of confidence in the company’s products.
“Both the regulatory landscape and the continued investments align to show demonstrated momentum,” said de Nood.
“We look forward to working closely with our investors as we enter our next growth phase and cement our position as global leaders in the cultivated meat industry.”